THAR on MEGA WATCH 📢 🎅 🎄
🔥 biotech company focused on interventions for inflammatory and oncologic diseases
🔥 Strong technical setup: 4-hour chart demonstrating bullish descending wedge
🔥 Strong pipeline with recently published positive Phase 1 data for TH104, its lead candidate for chronic pruritus in PBC
🔥 Market cap $1m, highly undervalued, should easily be a minimum $6m market cap
🔥Oversold, RSI 25
🔥 Recently closed offering (priced at $1.00/sh), now with enough cash for clinical and administrative operations through 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
A Bay Area health provider--know your fundamentals but never underestimate the impact that sentiment can have on a stock
255Followers
0Following
1026Visitors
Follow
Double_Bottom : looks like public offering of 10 millions shares diluted the stock price. despite the current good news stock price remain downward trend.